Partial Lower Axillary Dissection for Patients with Clinically Node-negative Breast Cancer

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.6, 2012-11, pp. : 2336-2345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Uracil/tegafur improves survival in node-negative breast cancer

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?

By Lamond Nathan WD Skedgel Chris Younis Tallal

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 243-250

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer

By Kandemir EG Mayadagli A Karagoz B Bilgi O Turken O Yaylaci M

The Journal of International Medical Research, Vol. 33, Iss. 2, 2005-03 ,pp. : 228-235

Field House Publishing

Access to resources Recommend Favorite

Neoadjuvant chemoradiation for non‐metastatic pancreatic cancer increases margin‐negative and node‐negative rates at resection

Journal of Digestive Diseases, Vol. 18, Iss. 11, 2017-11 ,pp. : 642-649

John Wiley & Sons Inc

Access to resources Recommend Favorite